John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), bought 1,000 shares at $11.57 ($12K) on 2014-12-29, disclosed to the SEC on 2014-12-29.
Scheduled purchase ($12k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |